The California State Board of Pharmacy filed a Statement of Issues seeking to deny an application for a pharmacist license based on events in April 2013. According to the filing, on or about April 1, 2013 the applicant contacted a licensed California physician and requested authorization of a Maxzide prescription, and later paid for a Maxzide prescription filled for a named patient. On or about April 16, 2013 the applicant allegedly re-authorized, filled, picked up and paid for a Lortab (hydrocodone) prescription for another patient. The Board alleged that none of these prescriptions was supported by an existing prescriber-patient relationship or examination.
The Board framed the conduct as a failure to exercise best professional judgment and corresponding responsibility in dispensing controlled substances and dangerous drugs. A separate cause alleged violations of controlled substance laws, specifically possession of marijuana and possession of Lortab hydrocodone without a prescription. These were allegations in a licensing filing, not findings after a hearing.
The excerpted record does not describe how the 2013 conduct first came to light. The allegations were raised when the Board reviewed the pharmacist license application and filed a Statement of Issues against it, which put the applicant's fitness for licensure before the Board.
The case was resolved by stipulated settlement. Under the Board's decision, effective October 15, 2025, the pharmacist license is granted and, once issued, immediately revoked with the revocation stayed and the license placed on probation for three years. Probation terms include periodic reports to the Board, made under penalty of perjury, on compliance with all conditions, and delinquent reporting may extend the probation period.